CRS: JHU
Position: Co-investigator
CRS: BJMC
Position: Dean, BJ Medical College and India CRS PI
Position: Study Coordinator
Position: CRS Leader
Position: CTU Leader for HPTN Studies
Position: Site Leader
Position: Global Community Advisory Board Representative
CRS: BJMCJHU
Position: Principal Investigator, Johns Hopkins Professor of Medicine and Public Health; Deputy Director, CCGHE
Position: CRS Data Manager and Deputy Director
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
